Onyx Pharmaceuticals, Inc. (ONXX) Wednesday reported a first-quarter loss of $56.2 million or $0.88 per share, which widened from $49.2 million or $0.78 per share in the same period last year.
Adjusted loss for the period was $43.5 million or $0.68 per share, compared to $14.2 million or $0.23 per share last year.
On average, 12 analysts polled by Thomson Reuters expected a loss of $0.63 per share for the first quarter. Analysts' estimates typically exclude special items.
First-quarter revenues increased 7 percent to $72.0 million from $67.1 million last year. Analysts expected revenues of $70.04 million for the period.
Operating expenses for the period totaled $122.8 million, up from $108.5 million last year.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org